Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial.
FLOW 試驗中 Semaglutide 對糖尿病和慢性腎病心衰竭結果的影響。
J Am Coll Cardiol 2024-09-01
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
FLOW試驗:一項針對2型糖尿病合併慢性腎臟病患者,使用每週一次semaglutide評估腎臟結果的研究之理念、設計和基線數據。
Nephrol Dial Transplant 2023-12-01
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
Semaglutide對基線腎功能參數不同的2型糖尿病患者及高心血管疾病風險者主要不良心血管事件的影響:SUSTAIN 6和PIONEER 6事後合併分析。
Cardiovasc Diabetol 2023-11-21
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.
在 FLOW 試驗中,Semaglutide 對於合併使用 SGLT2 抑制劑和未合併使用 SGLT2 抑制劑的 2 型糖尿病和慢性腎臟病患者的影響。
Nat Med 2024-06-24
Semaglutide in Heart Failure: A Systematic Review of Outcomes of Semaglutide in Heart Failure Patients.
心衰竭中的 Semaglutide:心衰竭患者中 Semaglutide 結果的系統性回顧。
Cureus 2024-08-16
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Semaglutide 與肥胖及心臟衰竭患者的心血管結果:SELECT 試驗的預先指定分析。
Lancet 2024-08-24
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.
2型糖尿病中慢性腎病嚴重程度對semaglutide心血管結果的影響:FLOW試驗。
Eur Heart J 2024-08-30
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
心衰竭患者中 Semaglutide 與安慰劑的比較:SELECT、FLOW、STEP-HFpEF 和 STEP-HFpEF DM 隨機試驗的綜合分析。
Lancet 2024-09-02